|
HS Code |
220396 |
| Active Ingredient | Ibuprofen |
| Strength | 200 mg |
| Dosage Form | Tablet |
| Route Of Administration | Oral |
| Manufacturer | Varies |
| Indications | Pain relief, fever reduction, inflammation |
| Package Quantity | 100 tablets |
| Prescription Status | Over-the-counter |
| Storage Conditions | Store at 20°C to 25°C (68°F to 77°F) |
| Expiration Date | See package |
| Color | White |
| Shape | Round |
| Imprint | Ibuprofen 200 |
| Inactive Ingredients | Lactose, starch, magnesium stearate, etc. |
| Common Side Effects | Nausea, dizziness, stomach pain |
As an accredited Ibuprofen Tablets factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White bottle with child-resistant cap, labeled "Ibuprofen Tablets, 200 mg," contains 100 tablets, includes dosage instructions and safety warnings. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for Ibuprofen Tablets: Securely packed cartons, optimized space, moisture-protected, palletized, sealed, compliant with pharmaceutical transportation standards. |
| Shipping | Ibuprofen Tablets should be shipped in tightly sealed containers, protected from moisture and direct sunlight. Transport at controlled room temperature, typically between 15°C and 30°C. Ensure the packaging is secure to prevent breakage or contamination, and clearly label with product, batch, and safety information in compliance with relevant regulations. |
| Storage | Ibuprofen Tablets should be stored at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). Keep them in a tightly closed container, protected from moisture, excessive heat, and direct light. Store out of reach of children and away from incompatible substances. Avoid storing in bathrooms or humid areas to maintain tablet stability and efficacy. |
| Shelf Life | The shelf life of Ibuprofen Tablets is typically 2-3 years when stored in a cool, dry place, away from sunlight. |
|
Purity 99%: Ibuprofen Tablets with 99% purity are used in post-operative pain management, where rapid onset of analgesia is achieved. Molecular Weight 206.29 g/mol: Ibuprofen Tablets specified at molecular weight 206.29 g/mol are used in treating musculoskeletal inflammation, where consistent anti-inflammatory response is maintained. Dissolution Rate ≥ 85% in 30 min: Ibuprofen Tablets meeting a dissolution rate of ≥ 85% in 30 minutes are used in acute migraine relief, where accelerated absorption ensures fast symptom control. Particle Size D90 ≤ 250 μm: Ibuprofen Tablets formulated with particle size D90 ≤ 250 μm are used in pediatric pain therapy, where enhanced bioavailability improves clinical efficacy. Stability Temperature ≤ 25°C: Ibuprofen Tablets stable at temperatures ≤ 25°C are used in tropical healthcare settings, where maintained potency throughout shelf life is ensured. Moisture Content ≤ 2%: Ibuprofen Tablets with moisture content ≤ 2% are used in hospital emergency kits, where degradation risk is minimized for reliable dosing. Melting Point 76–78°C: Ibuprofen Tablets characterized by melting point 76–78°C are used in chronic osteoarthritis management, where high thermal stability maintains drug integrity. Hardness 6–8 kp: Ibuprofen Tablets with hardness 6–8 kp are used in high-speed automatic packaging, where low breakage rate improves distribution efficiency. |
Competitive Ibuprofen Tablets prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
At the heart of everyday healthcare, ibuprofen tablets have carved out a space on medicine cabinets, first aid kits, and pharmacy shelves worldwide. Speaking not just as a producer, but as a team routinely handling ton after ton of active pharmaceutical ingredients, we witness firsthand the real-world impact that a simple, well-made tablet can deliver. Our ibuprofen tablets uphold the consistency and quality required by doctors, hospitals, and families, giving dependable relief for pain and inflammation — from headaches to backaches, from fevers to sore muscles.
This daily reality shapes the way we look at every batch in our facility. Every tablet rolling off our presses results from a carefully managed process, guided by a deep respect for safety and science. We know the crucial role each tablet can play in restoring comfort to someone’s day, so every step — weighing, mixing, pressing, coating, and packaging — gets our full attention.
Our ibuprofen tablets are available in commonly requested strengths, including 200 mg and 400 mg models, shaped for easy swallowing and coated for smooth taste. Regardless of dosage, our process prioritizes uniform distribution of the active ingredient — ensuring every dose matches pharmaceutical standards. You can visit pharmacies anywhere and likely find 200 mg ibuprofen, packaged by dozens of firms in many countries, yet not all tablets are alike. Subtle differences in particle size, binder materials, and disintegration profiles lead to real variances in performance. From the manufacturer’s side, we spend hours on physical testing, from hardness to dissolution time, not just because regulations demand it but because our reputation and conscience rest on the outcome.
Dosing accuracy makes the difference between safe, reliable relief and unpredictable results. Anyone who assembles tablets at scale understands that precise formulation and solid compaction prevent “dose dumping” — a problem when active ingredient releases too quickly, risking side effects or stomach irritation. We tune our process to hit the gold standard: rapid onset of action, gentle on the stomach, and steady relief over several hours. Our coated ibuprofen tablets consistently dissolve within 15 to 30 minutes, based on our own batch test results. Managing moisture content and choosing the right disintegrant mean our tablets perform as patients and providers expect, every time.
In the manufacturing world, shortcuts do not save time. We’ve learned that every hour saved by rushing compaction or skipping quality checks comes back to threaten overall yield. Tablets that chip, crumble, or don’t flow through packaging equipment increase waste and slow downstream handling. Our standard requires constant calibration and regular equipment maintenance.
GMP compliance isn’t just a poster in our facility. We train every new hire not only to follow procedures but to truly understand the importance of cross-contamination control, batch segregation, and sample tracking. Out-of-spec tablets get pulled — not just by random testing routines, but through hands-on supervision and accountability. Tablet color, odor, size, and film coating uniformity signal the quality customers expect when they open a foil pack or bottle.
Ibuprofen’s story began in the 1960s. Over the decades, it replaced aspirin for many as a gentler nonsteroidal anti-inflammatory drug. It works by blocking enzymes called COX-1 and COX-2, which convert arachidonic acid to prostaglandins — molecules that spark inflammation, swelling, and pain. Blocking these enzymes lowers fever and eases aches, but not all manufacturers balance efficacy and safety equally.
Too much compression pressure makes a tablet slow to dissolve; too little leaves them friable. Companies sometimes cut corners on lubrication or binders to save costs, affecting the rate of release or causing GI discomfort. We stick with proven excipients and test each new delivery for purity and bioavailability. Our in-house data show that maintaining a careful blend and controlling granulation make a real difference in patient experiences — less bitterness, softer swallowing, better pain relief.
Many customers ask what differentiates ibuprofen tablets from paracetamol (acetaminophen) or aspirin. While all three lower pain and fever, each works in unique ways — both at the molecular and clinical level.
Paracetamol is a strong fever reducer but offers comparatively weak anti-inflammatory effects. Doctors prescribe it for headaches and simple fevers but less so for sport injuries where swelling is a problem. Aspirin, while powerful, brings higher risk of stomach issues and cannot be given to children with viral infections due to Reye’s syndrome risk. Ibuprofen’s intermediate profile — decent anti-inflammatory effect, excellent fever control, easier on the stomach lining — has earned it a central place in both home and hospital settings.
Our manufacturing experience shows patients react differently. Ibuprofen in a properly manufactured tablet provides steady, reliable relief for arthritis, sprains, and muscle aches. We field calls from clinics looking for longer-acting, gentler options for their patients. This experience pushes us to keep refining formulation, sourcing better excipients, and updating our processes to keep pace with medical research.
A lot of talk in tablet manufacturing centers around parameters like hardness, disintegration time, and dissolution rate. From a practical standpoint, these affect more than just regulatory compliance. Tablets that break during shipment or stick in bottles lower customer confidence and often prompt returns. A batch that dissolves too slowly frustrates someone waiting for pain relief. In the factory, our team regularly samples product lines, tests at different stages, and tweaks the blend to ensure each batch meets the pharmacopeial monograph.
We track mechanical resistance closely. For instance, ibuprofen’s natural crystalline form drives a somewhat brittle tablet. Granulation helps, as does adding excipients like microcrystalline cellulose. Our team might spend days fine-tuning the moisture content and compression force just right, avoiding tablets that either shatter on drop tests or resist dissolving in stomach acid.
Not every manufacturer takes the same care. Some suppliers send us raw ingredient samples with a wide range of particle size and purity. Variations seem minor, but in real-world production, inconsistency leads to failed batches, lost time, and compromised safety. We work only with suppliers who guarantee tight particle size distribution and reliable, pharmaceutical-grade purity. Our own incoming materials pass through in-house chemical analysis on every shipment. It’s not just about ticking boxes — it’s about keeping the finished product trusted and safe.
Walk through any drugstore aisle and the variety of ibuprofen “models” becomes clear. Uncoated tablets, sugar-coated, film-coated, rapid-release, chewable, gel capsules — each with their own advantages and drawbacks. Most people do not realize that coatings do far more than color a product. They affect how quickly the active ingredient is available in the body, how well it resists humidity and breakage, and whether the taste or odor can be masked for sensitive users.
A film-coat makes swallowing easier, shields the taste, and gives the tablet added resistance against moisture and handling. Our customers regularly report that coated ibuprofen tablets are better tolerated and less likely to upset sensitive stomachs. The downside is increased production cost and extra quality checks to confirm even coating thickness. We accept that trade-off in the pursuit of better patient outcomes.
Additives like silica, magnesium stearate, and starches enable smoother manufacturing but must be strictly controlled. Overlubrication can slow dissolution. Our batch records show that even small deviations in lubricant quantity affect tablet friability and absorption. We keep detailed production logs, review results after every shift, and adjust as needed to hit our benchmarks.
Pharmaceutical manufacturing is unforgiving. A single mistake multiplies in scale. Our facility uses barcode tracking and electronic batch records, letting us trace every tablet from raw ibuprofen crystals to final packaging. Each active ingredient delivery comes with a full certificate of analysis, but we verify results through independent chromatography and spectrophotometry in our own quality lab.
To serve the broadest range of patients, we keep allergen cross-contact under strict control, running dedicated lines for differing products and performing full cleanouts between runs. Finished batch samples rest in stability chambers for months, simulating harsh transport and storage conditions. These accelerated studies show us tablet shelf life and any potential degradation well before shipping out large lots.
Tablets are packaged in blister packs or bottles, both tamper-evident and batch-numbered. This satisfies traceability for recalls and regulatory audits. Stories hit the industry press of counterfeit drugs or poor storage conditions causing product failures. Our end-to-end tracking and rigorous batch testing cut through those risks, ensuring that clinics and homes receive exactly what is promised.
Regulatory expectations have grown tougher year by year. As a manufacturer, this brings constant investment in updated equipment, methods, and staff training. Today’s market expects more than words — documentation, repeatable results, and proven quality drive purchasing decisions. We participate in both national and international audits, updating our own hazard analysis as new data emerges.
Medical professionals increasingly scrutinize data on excipient tolerances and pediatric dosing. From our side, we submit full information to health authorities, including impurity profiles, microbial load data, and risk assessments. Transparency and traceability are not “extras”, they are embedded practices. We see the connection — a pediatrician prescribing our tablets to a sick child, expecting unwavering consistency.
When feedback arrives, whether through healthcare providers or direct consumers, it shapes the next cycle of production. We adapt packaging to improve safety (child-resistant caps, for example) and adjust bulk pack sizes for hospitals or clinics as use scenarios change. Echoes of that real-world use ripple through our shop floor, daily meetings, and long-term planning.
Process improvement is never finished in this business. We’ve introduced in-line weight monitoring, automating discard of out-of-spec tablets. We’re investing in new press technology for faster changeovers and tighter granule control. Each investment means less human error, faster throughput, and better compliance with evolving standards.
Our chemists and engineers study dissolution profiles, tweaking formulations to further reduce GI irritation — particularly for chronic users with sensitive stomachs. Research partnerships with universities allow us to pilot new types of binders and coatings. Not every test pans out, but our failures teach as much as our successes. Batch recalls are rare for us, and each one prompts a full root-cause analysis, systems update, and retraining where needed. The lessons become part of ongoing guidelines for the next team member, batch, or product line.
Large hospitals order bulk ibuprofen tablets for post-op and chronic care. Community health clinics call for pediatric-appropriate doses or easy-to-divide tablets. Sports medicine facilities seek fast-release coatings. Retail chains want reliable packaging and long shelf life. Meeting these needs means adapting production schedules, reformulating for rapid-release or chewable formats, and working with distribution partners to minimize transport delays.
We’ve built lines capable of making both standard and specialty ibuprofen products, such as rapid-acting variants for emergency rooms and smooth-coated versions for patients with swallowing difficulties. While these lines increase complexity, they make it possible to offer options that genuinely match the varied demands of hospitals, pharmacies, and families.
Our team monitors seasonal patterns — spikes after school sports seasons, or flu season surges — and flexes capacity accordingly. Real-time production data flows into logistics planning, syncing shipment timing to match demand. Some years, raw material shortages challenge even the best run plants. We respond by keeping safety stock and cultivating a supplier network that emphasizes traceability and rapid response.
Quality incidents — from recalls due to incorrect labeling to foreign particles in pill bottles — hurt trust across the sector. We face the same risks as any manufacturer, but we have learned that proactive prevention beats reactive crisis management every time. Equipment gets preventive maintenance on strict schedules; employee training does not just cover procedures, but encourages a “stop if uncertain” mindset. If a tablet falls off spec, the line stops. Everyone from the line leader to the plant manager knows that small issues scale rapidly in pharmaceutical production.
Certain challenges lie beyond any single company’s control — global price instability for certain excipients, evolving regulatory standards, climate impacts on raw material quality. Our approach: communicate openly with customers about batch lead times, work closely with suppliers to guarantee quality, and retain a hands-on problem-solving focus. Quality, safety, and reliability remain the non-negotiables.
Every bottle of ibuprofen tablets represents more than a finished product; it stands for hours of behind-the-scenes work — careful sourcing, skilled blending, constant monitoring, and rigorous checking. In hospitals, one missed dose can delay healing. For parents, a reliable fever reducer brings peace of mind in the middle of stressful nights. For athletes, fast pain relief keeps recovery on track after an injury. We see feedback from every corner of the world, and every comment ties back to choices made on our shop floor.
Doctors relay stories of patients who finally found an over-the-counter solution that didn’t upset their stomach. Nurses appreciate tablets that are easy to divide and administer. Pharmacists trust in stable shelf life and clear labeling. The real world impact of small manufacturing decisions becomes clear, every day, in these patient and provider outcomes.
As expectations evolve, so does our approach. We track new research on ibuprofen metabolism and dosing, and look for ways to make the product more accessible, easier to swallow, and less prone to irritation. Investments in automation and quality control empower our teams to catch problems early and keep risk low. Focusing on continuous improvement helps us align with best practices highlighted in medical and regulatory literature.
Laboratory staff share space with production team leads; R&D specialists work directly with operators during formulation changes. Batch release is never a rubber-stamp. Each tablet, from our standard 200 mg line to specialty pediatric runs, reflects deliberate choices and direct responsibility. As pharmaceutical science advances, we stay committed to learning and adapting, delivering reliable pain relief with a conscience.
Manufacturing ibuprofen tablets is a craft as much as a science. Years of experience blend with ongoing scrutiny of every tablet, every shift, every shipment. Our aim: to deliver a product that meets the real-world demands of modern healthcare and home care alike. From raw materials to final packaging, accountability and patient outcomes drive everything we do. By keeping our promises to those who rely on our products, we know each batch brings pain relief, comfort, and trust to families, clinics, and hospitals everywhere.